Peptidyl-cysteine modification

pathway activity — cross-omics
GO:0018198Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-cysteine modification pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are ENPP5, RPRD2_S614, and RLIM_S164, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-cysteine modification activity versus ENPP5 in GBM (Pearson r = 0.21).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMENPP5 →+0.505+0.059<.001<.00135
LUADRPRD2_S614 →+0.417+0.030<.001.00234
HNSCRLIM_S164 →-0.492-0.070.004.00234
PDACEPB41L2_S16 →+0.572+0.039.008<.00134
GBMPCLO_S906 →+0.792+0.053<.001<.00134
LSCCPPP1R12A_S995 →-0.583-0.026<.001.00334
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018198 vs ENPP5 — GBM

Per-sample scatter of Peptidyl-cysteine modification activity vs ENPP5 in GBM.

Explore this scatter interactively →

Exploration